Alan Venook, MD

Gastrointestinal Oncology UCSF

Our Care Team

Chloe Atreya, MD, PhD

Emily Bergsland, MD

Eric Collisson, MD

Katie Kelley, MD

Andrew Ko, MD

Michael Korn, MD

Margaret Tempero, MD

Katherine Van Loon, MD, MPH

Alan Venook, MD

Alan Venook Alan Venook, MD is Professor of Clinical Medicine and the Madden Family Distinguished Professor of Medical Oncology and Translational Research at the University of California, San Francisco (UCSF).

Dr. Venook hails from Metuchen, NJ; he received a BA in Biological Sciences from Rutgers College in 1976 (a year in which, as Sports Editor of the Rutgers Daily Targum he also sat courtside for the NCAA Final Four in Philadelphia, PA.) 

He received his MD Degree in 1980 from UCSF, completed his internship at UCSF in 1981, then spent two years at an Urban Indian clinic in Sacramento California (to fulfill a commitment to the public Health Service) and then completed a residency in Internal Medicine at the University of California, Davis.  He returned to UCSF as  a Hematology / Oncology Fellow in 1985, joining the faculty in 1988.

Dr. Venook’s initial clinical research projects involved multidisciplinary collaborations with interventional radiologists and surgeons to treat liver tumors via the hepatic artery.  His first major publication in 1990 described the UCSF experience with chemoembolization for patients with hepatocellular carcinoma and is well known for his clinical research of new modalities to treat both primary and metastatic tumors of the liver.  In fact, he served as the founding Chair of the National Cancer Institute’s Hepatobiliary Task Force from 2006-2010.

The Gastrointestinal Oncology Program was started through a collaboration with surgeon Dr. Robert Warren in 1991 and the program now has ten physicians and physician/scientists in medical oncology.  One of two UCSF MD’s to become affiliated with the Cancer and Leukemia Group B in 1988, Dr. Venook has chaired and/or authored six major studies within the cooperative groups and he now Chairs the GI Committee of the Alliance for Clinical Trials in Oncology (formerly CALGB.)  He has also been an Associate Editor of the Journal of Clinical Oncology since 2009.